Cargando…
Feasibility and ethical issues: experiences and concerns of healthcare workers regarding a new RSV prophylaxis programme in Nunavik, Quebec
Background: The respiratory syncytial virus (RSV) is a major cause of hospitalisation in young Inuit children. Prophylaxis with palivizumab is routinely recommended for premature infants and those with severe pulmonary or cardiac diseases. In the fall 2016, the Quebec Ministry of Health expanded the...
Autores principales: | Lorcy, Armelle, Gilca, Rodica, Dubé, Eve, Rochette, Marie, De Serres, Gaston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144279/ https://www.ncbi.nlm.nih.gov/pubmed/32191589 http://dx.doi.org/10.1080/22423982.2020.1742564 |
Ejemplares similares
-
Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada
por: Gilca, Rodica, et al.
Publicado: (2020) -
Trends of Hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003
por: Canuel, Magalie, et al.
Publicado: (2007) -
Assessment of the implementation fidelity of the Arctic Char Distribution Project in Nunavik, Quebec
por: Gautier, Lara, et al.
Publicado: (2016) -
Inuit interpreters engaged in end-of-life care in Nunavik, Northern Quebec
por: Hordyk, Shawn Renee, et al.
Publicado: (2017) -
Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis
por: Ouldali, Naïm, et al.
Publicado: (2023)